ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.027,59
-0,38%
S&P 500
5.308,15
1,17%
US Dollar vs BRL
5,1357
0,12%
Bitcoin
66.027,27
7,28%
Brent Oil
82,65
0,12%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) Notícias

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:ROQ
DataHoraFonteTítuloCódigoCompanhia
26/04/202416:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
05/04/202408:32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202403:00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
11/03/202408:12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202404:00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
06/02/202413:50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202404:00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
24/11/202304:00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
06/11/202309:01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202304:00UK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
27/09/202311:43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202303:00UK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
22/09/202307:42RNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
14/08/202307:07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202303:00UK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
07/08/202307:04Alliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
07/08/202303:00UK RegulatoryRoquefort Therapeutics PLC Development of New Novel siRNA TherapeuticsLSE:ROQRoquefort Therapeutics Plc
02/08/202303:00UK RegulatoryRoquefort Therapeutics PLC Director/PDMR ShareholdingLSE:ROQRoquefort Therapeutics Plc
29/06/202314:51Alliance NewsAlliance NewsTRADING UPDATES: Anpario trading in line, Likewise Group sales riseLSE:ROQRoquefort Therapeutics Plc
29/06/202306:05UK RegulatoryRoquefort Therapeutics PLC Results of AGMLSE:ROQRoquefort Therapeutics Plc
29/06/202303:00UK RegulatoryRoquefort Therapeutics PLC AGM StatementLSE:ROQRoquefort Therapeutics Plc
22/06/202316:34Alliance NewsAlliance NewsTRADING UPDATES: Plant Health Care announces GBP2.8 million fundraiseLSE:ROQRoquefort Therapeutics Plc
22/06/202303:00UK RegulatoryRoquefort Therapeutics PLC RNA Medicine Shows In Vitro Anti-Cancer EfficacyLSE:ROQRoquefort Therapeutics Plc
19/06/202308:28Alliance NewsAlliance NewsRoquefort Therapeutics celebrates cancer antibody trial resultsLSE:ROQRoquefort Therapeutics Plc
19/06/202303:00UK RegulatoryRoquefort Therapeutics PLC Antibody Program Results & Orphan Drug IndicationLSE:ROQRoquefort Therapeutics Plc
13/06/202307:52Alliance NewsAlliance NewsIN BRIEF: Roquefort says anti-cancer mRNA study shows positive resultsLSE:ROQRoquefort Therapeutics Plc
13/06/202303:00UK RegulatoryRoquefort Therapeutics PLC Anti-Cancer MDK mRNA - Positive in vitro ResultsLSE:ROQRoquefort Therapeutics Plc
07/06/202310:41Alliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics suspension on shares liftedLSE:ROQRoquefort Therapeutics Plc
07/06/202306:11UK RegulatoryRoquefort Therapeutics PLC Restoration of TradingLSE:ROQRoquefort Therapeutics Plc
 Apresentando as notícias mais relevantes sobre:LSE:ROQ

Seu Histórico Recente

BOV
ELETQ38
ELETQ38 Ex:36,18
EU
R159S
R159S
BIT
Q00577
Leonteq Securities
USOTC
SDRMF
SiteMinder (PK)
FTSE
HIX
FTSE 350 Index Higher Yi...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados